Trial site
Medivasa s.r.o.
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- Atrial fibrillation3 trials
- Chronic kidney disease3 trials
- Stroke3 trials
- Type 2 diabetes3 trials
- High blood pressure2 trials
- Obesity2 trials
- Coronary artery disease1 trial
- Diabetic eye disease1 trial
- Familial hypercholesterolaemia1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 316 trials
- Phase 23 trials
- Status
- Active, not recruiting7 trials
- Completed7 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca3 trials
- Novo Nordisk A/S3 trials
- Arrowhead Pharmaceuticals2 trials
- Cardurion Pharmaceuticals Inc.2 trials
- Eli Lilly and Company2 trials
- and 5 more
Running trials
Not yet recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026